| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |